MedTrace Logo

Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting

NCT00207584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2005-09-21

No results posted yet for this study

Summary

This study was designed to determine whether taking daily doxycycline during an outbreak of Mycoplasma pneumoniae could prevent a person from getting infected and interrupt ongoing disease transmission during an outbreak. Doxycycline is a treatment for Mycoplasma pneumoniae, but it is not certain that the drug could prevent disease if used prophylactically.

Conditions

  • Mycoplasma Pneumoniae

Interventions

DRUG

Doxycycline treatment

Sponsors & Collaborators

Principal Investigators

  • Julia A Schillinger, MD · Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1994-01-31
Completion
1994-04-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00207584 on ClinicalTrials.gov